Hemoglobin chyle joint detection device and detection method
By designing a hemoglobin chylo detection device, using a dual-wavelength correction algorithm and Lambert Beer's law, synchronous quantitative analysis of hemoglobin concentration and chylo degree is achieved, solving the problems of low detection efficiency and limited accuracy in the existing technology, and improving the automation and accuracy of the primary screening before blood donation.
Patent Information
- Application Number
- CN202510897469.8
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-01
- Publication Date
- 2025-08-01
- Estimated Expiration
- 2045-07-01
AI Technical Summary
The prior art cannot synchronize, quickly and accurately detect the hemoglobin content and chylo blood in the blood, resulting in low efficiency of initial screening before blood donation and the accuracy is affected by the experience of the examiner.
A hemoglobin chylobin combined detection device is designed, and the dual-wavelength correction algorithm is used to synchronize absorbance signals at wavelengths of 480-570nm and 580-700nm through the optical detection module, and a simultaneous quantitative analysis of hemoglobin concentration and chylo degree is achieved by combining Lambert Beer's law.
The dual-parameter synchronous analysis of hemoglobin and chylo is realized, the efficiency of initial screening before blood donation is improved, the interference is eliminated, and the direct detection of whole blood is supported. It is suitable for rapid screening on site for blood collection, and the information management of detection data is realized.